Company Filing History:
Years Active: 2006-2007
Title: Eberhard Hildt: Innovator in Cell Permeability and Gene Therapy
Introduction
Eberhard Hildt is a notable inventor based in Berlin, Germany. He has made significant contributions to the fields of cell permeability and gene therapy. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Hildt's latest patents include innovative technologies that enhance cell permeability. The first patent, titled "Polypeptide mediating cell permeability," describes a cell-permeable polypeptide that facilitates the entry of substances into cells. This invention also encompasses DNA coding for the polypeptide and methods for its production. Additionally, it includes antibodies directed against the polypeptide, highlighting its potential use in mediating cell permeability.
The second patent, "Particles for gene therapy," focuses on particles that consist of a protein envelope containing a fusion protein. This fusion protein includes a virus protein, a cell permeability-mediating peptide, and a heterologous cell-specific binding site. The nucleic acid within the protein envelope comprises a virus-specific packaging signal and a structural gene. This invention outlines methods for preparing such particles and their applications in gene therapy.
Career Highlights
Throughout his career, Eberhard Hildt has worked with various companies, including Island Pharmaceuticals Ltd. and Island Pharmaceuticals, Ltd. His expertise in the field has allowed him to contribute to groundbreaking research and development.
Collaborations
Hildt has collaborated with notable individuals in his field, including Peter Hofschneider and Stephanie Schmidt. These partnerships have furthered his research and innovation efforts.
Conclusion
Eberhard Hildt's contributions to cell permeability and gene therapy demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biological processes and hold promise for future therapeutic applications.